Literature DB >> 20229256

In vitro metastatic colonization of human ovarian cancer cells to the omentum.

Shaheena M Khan1, Holly M Funk, Sophie Thiolloy, Tamara L Lotan, Jonathan Hickson, Gail S Prins, Angela F Drew, Carrie W Rinker-Schaeffer.   

Abstract

Despite the potentially crucial contributions of the omentum in the regulation of ovarian cancer metastatic growth, it remains a poorly understood organ. Due to its anatomic location and structural fragility, the omentum presents inherent challenges to mechanism-based in vivo studies. Thus, the availability of an ex vivo omental model would, in part, address some of these difficulties posed. Here we describe a technique for identifying, isolating and maintaining ex vivo cultures of omenta from immune-compromised and -competent mice. Ex vivo culture conditions were developed that maintain tissue viability, architecture, and function for up to 10 days. Further experiments demonstrate that the ex vivo culture conditions allow for the proliferation of ovarian cancer cells in vitro and support a similar pattern of microscopic lesions after either intraperitoneal injection of ovarian cancer cells or co-culture of ovarian cancer cells with the omentum. In agreement with previous studies from our laboratory, histologic evaluation of these specimens found that ovarian cancer cells, as well as other peritoneal cancer cells, preferentially accumulate in, and colonize, omental areas rich in immune cells. We now recognize that these are specific, functional structures referred to as milky spots. In sum, these are foundational studies of a readily accessible model, which is easily manipulated and can be immediately used to study the dynamic process of omental colonization. It is hoped that investigators will use the data herein as a starting point for refinements and modifications which will enable them to tailor the model to the specific needs of the experimental question(s) they wish to pursue.

Entities:  

Mesh:

Year:  2010        PMID: 20229256     DOI: 10.1007/s10585-010-9317-0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  31 in total

1.  Mesothelial cells induce the motility of human ovarian carcinoma cells.

Authors:  M Rieppi; V Vergani; C Gatto; G Zanetta; P Allavena; G Taraboletti; R Giavazzi
Journal:  Int J Cancer       Date:  1999-01-18       Impact factor: 7.396

2.  Isolation, culture and characterization of human peritoneal mesothelial cells.

Authors:  E Stylianou; L A Jenner; M Davies; G A Coles; J D Williams
Journal:  Kidney Int       Date:  1990-06       Impact factor: 10.612

3.  In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation.

Authors:  T Strobel; L Swanson; S A Cannistra
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

4.  Pancreatic tissue formation from murine embryonic stem cells in vitro.

Authors:  Mio Nakanishi; Tatsuo S Hamazaki; Shinji Komazaki; Hitoshi Okochi; Makoto Asashima
Journal:  Differentiation       Date:  2007-01       Impact factor: 3.880

5.  Mesothelial stomata overlying omental milky spots: scanning electron microscopic study.

Authors:  V A Mironov; S A Gusev; A F Baradi
Journal:  Cell Tissue Res       Date:  1979-09-03       Impact factor: 5.249

6.  Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth.

Authors:  Scott A Gerber; Viktoriya Y Rybalko; Chad E Bigelow; Amit A Lugade; Thomas H Foster; John G Frelinger; Edith M Lord
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

7.  The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.

Authors:  Jonathan A Hickson; Dezheng Huo; Donald J Vander Griend; Anning Lin; Carrie W Rinker-Schaeffer; S Diane Yamada
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

Review 9.  Learning therapeutic lessons from metastasis suppressor proteins.

Authors:  Steven Christopher Smith; Dan Theodorescu
Journal:  Nat Rev Cancer       Date:  2009-02-26       Impact factor: 60.716

10.  Metastasis suppressors and the tumor microenvironment.

Authors:  Thomas M Bodenstine; Danny R Welch
Journal:  Cancer Microenviron       Date:  2008-01-31
View more
  29 in total

1.  Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells.

Authors:  Mijung Kim; Lisa Rooper; Jia Xie; Andre A Kajdacsy-Balla; Maria V Barbolina
Journal:  Mol Cancer Res       Date:  2011-11-07       Impact factor: 5.852

2.  Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models.

Authors:  Robert Clark; Venkatesh Krishnan; Michael Schoof; Irving Rodriguez; Betty Theriault; Marina Chekmareva; Carrie Rinker-Schaeffer
Journal:  Am J Pathol       Date:  2013-08       Impact factor: 4.307

Review 3.  Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression.

Authors:  H Chkourko Gusky; J Diedrich; O A MacDougald; I Podgorski
Journal:  Obes Rev       Date:  2016-07-19       Impact factor: 9.213

Review 4.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

5.  Interleukin-6 receptor enhances early colonization of the murine omentum by upregulation of a mannose family receptor, LY75, in ovarian tumor cells.

Authors:  Premkumar Vummidi Giridhar; Holly M Funk; Catherine A Gallo; Aleksey Porollo; Carol A Mercer; David R Plas; Angela F Drew
Journal:  Clin Exp Metastasis       Date:  2011-09-02       Impact factor: 5.150

Review 6.  Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

Authors:  Khalid El Bairi; Abdul Hafeez Kandhro; Adel Gouri; Wafaa Mahfoud; Noureddine Louanjli; Brahim Saadani; Said Afqir; Mariam Amrani
Journal:  Cell Oncol (Dordr)       Date:  2016-12-15       Impact factor: 6.730

7.  The mannose-sensitive hemagglutination pilus strain of Pseudomonas aeruginosa shift peritoneal milky spot macrophages towards an M1 phenotype to dampen peritoneal dissemination.

Authors:  Zhi-Feng Miao; Ting-Ting Zhao; Feng Miao; Zhen-Ning Wang; Ying-Ying Xu; Xiao-Yun Mao; Jian Gao; Jian-Hua Wu; Xing-Yu Liu; Yi You; Hao Xu; Hui-Mian Xu
Journal:  Tumour Biol       Date:  2014-01-03

8.  Quantitative proteomic analysis of murine white adipose tissue for peritoneal cancer metastasis.

Authors:  Peter E Feist; Elizabeth A Loughran; M Sharon Stack; Amanda B Hummon
Journal:  Anal Bioanal Chem       Date:  2017-12-27       Impact factor: 4.142

Review 9.  Suppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptor.

Authors:  Panida Lungchukiet; Yuefeng Sun; Ravi Kasiappan; Waise Quarni; Santo V Nicosia; Xiaohong Zhang; Wenlong Bai
Journal:  J Steroid Biochem Mol Biol       Date:  2014-11-06       Impact factor: 4.292

Review 10.  Three-dimensional modeling of ovarian cancer.

Authors:  Erin A White; Hilary A Kenny; Ernst Lengyel
Journal:  Adv Drug Deliv Rev       Date:  2014-07-14       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.